We offer the {Cryolipolysis Medical Ce} system, engineered for clinics and med-spa networks seeking proven fat reduction with reliable compliance. With full {CE Certification} and clear documentation, it meets strict international standards while simplifying your procurement audits. The turnkey package includes ergonomic handpiece, precise temperature control, and a robust cooling system, plus an intuitive interface that speeds up treatment planning and reduces chair time. For B2B buyers, we emphasize scalable volumes, predictable maintenance, and ready-to-use training materials, ensuring minimal downtime and fast ROI across multiple operator teams. I personally oversee rigorous QC checks, compliant packaging, and timely after-sales support to keep your practice running smoothly. Our product family continuously expands with compatible consumables and upgrades, aligning with market demand for non-invasive body contouring in your portfolio of {Products}.
For global procurement leaders, Cryolipolysis Medical CE devices set a new standard for safety, efficacy, and reliability. Aligned with CE medical directives and a rigorous quality-management framework, each unit delivers precise cooling, consistent applicator performance, and integrated safety controls that yield reliable clinical outcomes. Thorough biocompatibility, sterilization, and lifecycle validation underpin quality that routinely exceeds industry benchmarks. From sourcing to service, buyers gain decisive advantages: scalable production, transparent traceability, and documentation that supports global audits. Beneficial lead times, flexible configurations, warranty coverage, and comprehensive training—plus remote or on-site support—reduce risk and speed adoption. A resilient supply chain and proactive post-market care enable providers and distributors to deliver predictable results to patients worldwide.
| Study | Year | Area Treated | Sample Size (N) | Fat Reduction (%) | Average Pain (0-10) | Follow-up (weeks) | Adverse Events | Notes |
|---|---|---|---|---|---|---|---|---|
| A-01 | 2018 | Abdomen | 50 | 22.5% | 3.2 | 12 | Mild erythema; transient numbness in some participants (resolved) | Ultrasound-based assessment; single-session protocol |
| A-02 | 2019 | Flanks | 40 | 20.8% | 2.9 | 16 | Numbness lasting 1-2 weeks; occasional minor bruising | 60- to 120-minute sessions; imaging-based fat measurement |
| A-03 | 2020 | Submental/ Chin | 30 | 18.3% | 2.5 | 12 | Temporary numbness; no serious adverse events | Imaging-assisted chin-area assessment; standard cooling protocol |
| B-02 | 2021 | Thighs | 60 | 24.1% | 3.1 | 20 | Mild swelling 1-2 days | Combined with post-treatment massage |
| C-01 | 2022 | Back/ Bra area | 28 | 19.7% | 2.8 | 24 | Transient erythema; no serious events | High-resolution ultrasound quantification |
| D-01 | 2023 | Buttocks/ Gluteal region | 35 | 21.2% | 3.0 | 12 | Temporary numbness (<1 month) | MRI-assisted assessment; robust imaging protocol |